Panacea Biotec announces signing of agreement with Technology Development Board (TDB), Govt. of India, regarding financial assistance for development & commercialization of Dengue Tetravalent Vaccine

Panacea Biotec Announces Launch of Prasugrel Tablets (its first-to-file ANDA) in US Market

Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control

Panacea Biotec and Apotex Inc.expand collaboration to lunch Prasugrel in USA

‍

Panacea Biotec Announces Joint Collaboration with Bionpharma Inc.

‍

Panacea Biotec Introduces World's First Fully Liquid Hexavalent Combination Vaccine EasySixTM for Six Preventable Diseases

‍

Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Supply of Pentavalent Vaccine (Easyfive-TT)

‍

Panacea Biotec Ensures Increased availability of Life Saving Drug Cilamin 250 (D-Penicillamine IP 250mg) Capsules for Treatment of Wilson's disease in India

‍

Panacea Biotec Introduces fully liquid Tetravalent Vaccine Easyfour-TT against DTP and Hib

‍

Panacea Biotec announces Receipt of Establishment Inspection Report (EIR) from USFDA for its pharmaceutical facilities at Baddi

‍